Performance of image-guided bone biopsies in malignant lesions: impact of PET/CT metabolic activity on the number of samples required
This study assessed whether metabolic activity on FDG PET/CT influences the diagnostic yield of IGBB. High metabolic activity did not allow for reducing the number of samples without affecting diagnostic performance. At least three biopsy samples should be obtained, prioritizing safety over metabolic activity when selecting the biopsy site.
Authors
- Vincent Habouzit (ORCID: https://orcid.org/0000-0001-8671-2292)
- P.B. Bonnefoy (ORCID: https://orcid.org/0000-0002-6334-7066)
- Sylvain Grange (ORCID: https://orcid.org/0000-0003-3706-297X)
- Rémi Grange (ORCID: https://orcid.org/0000-0002-7465-2955)
- Michel Péoc’h (ORCID: https://orcid.org/0000-0001-5453-0021)
- Claire Boutet (ORCID: https://orcid.org/0000-0001-9850-4124)
- Mathieu Conjeaud
Institutions
- Inserm (FR)
- Mines Saint-Étienne (FR)
- Centre Hospitalier Universitaire de Saint-Étienne (FR)
Publication Details
- Journal
- Insights into Imaging
- Published
- 2025-10-31
- DOI
- https://doi.org/10.1186/s13244-025-02130-2
- Primary Topic
- Medical Imaging Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00